The Neuro Event Labs leadership team has been selected as the winner of the 2018 Tampere City Innovation Award. The selection committee highlighted the team’s innovative solution utilizing the latest computer vision and machine learning technologies, combining those technologies to solve real problems in epilepsy. Neuro Event Labs’ product, Nelli, helps doctors to better diagnose and monitor patients, especially in home environments as part of the patient’s normal life. Objective and automatic epilepsy monitoring enables in-home observations with few constraints, making it possible to tailor a personalized treatment for each patient.
Read more about the 2018 Tampere City Innovation Award here (article in Finnish).
Last year at Slush, we demonstrated our AI-powered epilepsy monitoring service to a wider audience. Since then, we have doubled our efforts to provide a stronger and smarter deep learning system that can help neurologists to utilize the quantitative and objective data that we provide; something we already see providing better individualized treatment for patients with epilepsy. →
Neuro Event Labs has been selected in a new venture capital fund founded by leading Finnish technologists. The fund invests 500,000 Euros in the company. This complements an investment of 100,000 Euros by OmaMedical and 1.3 million Euros made by Business Finland, a Finnish national growth acceleration organization. The new fund being established, Maki․vc, will become a major Nordic venture capital fund with up to 70 million Euros (approx․ 86 million USD) total fund size. →
Tampere University Hospital (Tays), Neuro Event Labs’ key client, has been using our epilepsy monitoring solution together with a vagus nerve stimulator (VNS) to treat patients with epilepsy and to evaluate the effectiveness of the treatment. As part the cooperation, a Tays patient used NEL’s night-time epilepsy monitoring solution for a full month, right at the patient’s home. →